Citigroup
CPHR

Citigroup’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Citigroup’s Portfolio CPHR Stock Details CPHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,933
Closed -$18K – 7970
2015
Q1 		$18K Sell
1,933
-869
-31% -$10.9K ﹤0.01% 6160
2014
Q4 		$40K Buy
+2,802
New +$40.7K ﹤0.01% 5841

Other funds holding CPHR

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
IIM
Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
TAM
Taylor Asset Management Toronto, Ontario, Canada $154M AUM 10.32% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return

Citigroup's CPHR Position: Q2 2015 in Review

Citigroup sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q2 2015, closing a stake of 1,933 shares — an estimated $18K sold.

Citigroup first reported a position in CPHR in Q4 2014 and held it in 2 quarters. The position peaked at $40K in Q4 2014. 25 funds tracked by Wall St. Rank hold CPHR as of Q2 2015.

  • Citigroup reported no remaining Cipher Pharmaceuticals Inc. position as of Q2 2015 after selling out during the quarter.
  • Citigroup sold 1,933 Cipher Pharmaceuticals Inc. shares in Q2 2015, an estimated $18K.
  • Citigroup first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 2 quarters.
  • Citigroup's Cipher Pharmaceuticals Inc. position peaked at $40K in Q4 2014.
  • 25 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q2 2015.

Based on Citigroup's 13F filing for Q2 2015, filed 13 Aug 2015.